Generic Injectables Market: Global Industry Trends, Growth, Share and Regional Forecast Till 2023

Global Generic Injectables Market Report and Analysis of Top Key Players

Copyright © IMARC Service Pvt Ltd. All Rights Reserved

About IMARC Group

Report Description

IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Generic Injectables Market Report By Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition and Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel, Region The global generic injectables market has witnessed a healthy growth over the past few years. This can be attributed to the aging population coupled with rapidly increasing cases of chronic diseases and unhealthy lifestyle.

Market Overview: Generic injectables refer to medication which yields the same therapeutic effect as their innovator drugs since they have the similar active ingredients, strength, quality, performance, intended use and dosage. Owing to their low cost, generic injectables have gained popularity in the healthcare sector.

Moreover, the number of competitors in the generic injectables market is lower in comparison to oral generics which has resulted in higher profit margins and limited price erosion. A new research report

by IMARC Group, titled “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, estimates that the market was worth US$ 26.2 Billion in 2017.

The report further anticipates the market to reach US$ 45 Billion by 2023, at a projected CAGR of 9.5% over the forecast period.

Report Description and Highlights Report Description Global Generic Injectables Market Drivers/Constraints: • • • •

The numerous advantages of generic injectables, including low cost, short approval time and low capital investment compared to brand name injectables are catalysing the generic injectables market across the globe.

The governments of various countries are supporting the manufacturing of generic injectables as these drugs help to reduce the healthcare costs. This has given an impetus to the market growth.

Some of the other factors fuelling the growth of the market are the growing geriatric population, patent expiry of a number of drugs, rising prevalence of chronic diseases and an increase in drug shortages.

The negative perception of the consumers towards generic drugs coupled with stringent regulations laid down by the governments are some of the challenges faced by the global generic injectables market.

Generic Injectables Market Segmentation: Market Segmentation by Therapeutic Area o Oncology

Market Forecast

Sample Figure: Global: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2018 - 2023

184.3

191.7

199.3

207.3

2018

2019

2020

2021

215.6

224.2

2022

2023

Market Segmentation

Report Description o o o o

Anaesthesia Anti-infectives Parenteral Nutrition Cardiovascular

On the basis of therapeutic area, oncology accounts for the majority of the global share. The rising concerns over cancer coupled with oncology drugs going off-patent is projected to fuel the growth of this segment. Other major therapeutic areas include anaesthesia, cardiovascular, anti-infectives and parenteral nutrition.

Market Segmentation by Container • • • •

Vials Ampoules Premix Prefilled Syringes

On the basis of container the market segment as , vials, ampoules, premix and prefilled syringes For more information, click here: https://www.imarcgroup.com/generic-injectables-market

Market Segmentation

Report Description

Request for a sample report: https://www.imarcgroup.com/request?type=report&id=804&flag=B Market Segmentation by Region • • • • •

North America Europe Asia Pacific Latin America Middle East and Africa

On a geographical front, the market has been segregated into Asia, North America, Europe, Latin America, and Middle East and Africa. Currently, North America represents the leading market on account of an increase in chronic diseases due to sedentary lifestyle and poor eating habits of the population.

Market Segmentation by Distribution Channel • •

Hospitals Retail Pharmacy Stores

Based on distribution channel, the market has been segmented into hospitals and retail pharmacy stores.

Amongst these, hospitals represent the leading segment as generic injectables cannot be administered or traded without medical assistance or permission from a certified practitioner.

Regional Segmentation

North America

Europ e

Asia- Pacific

Latin America

Middle East and Africa

Market Segmentation

Report Description Competitive Landscape:

The market is highly concentrated with the presence of a handful of manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are: • • • • • •

Hospira (Pfizer Inc.) Fresenius Kabi Ag Hikma Pharmaceuticals PLC Sandoz (Novartis) Sagent Pharmaceuticals, Inc. (Nichi-Iko Pharmaceutical Co. Ltd.) Sanofi

In case you have a very specific customized or specific niche needs, we can work around the scope of work and assist you with the tailor made solution. The topics covered could be technology, markets, competition, pricing trends, P&L analysis, cost analysis, price bench marking or it could also be supplementing you with the weekly or fortnight reports.

Team Profile

Team Profile Our Team Comes From Some of the Top Universities Globally.

60% Engineering and Science

5% Others

35% Business Studies

Over 2000 Independent Consultants from different sectors.

Average Experience of 7+ Years

We are the trusted business partners to the

Partial List of Clients world's leading corporates, governments, and A partial List of our Clients institutions

We are the trusted business partners to the

Partial Listworld's of Clients leading corporates, governments, and

A partial List of our Clients

institutions

Report Description and Highlights

Report Description

© 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com